Adaptive functioning in pediatric epilepsy: contributions of seizure-related variables and parental anxiety

Valerie Kerne1, Lynn Chapieski1

  • 1Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA; Section of Psychology, Texas Children's Hospital, 6701 Fannin, CC-1630, Houston, TX 77030, USA.

Insights

Pediatric epilepsy patients with intractable seizures face challenges in independence. Key risk factors include seizure type, duration, medication, and age at onset, impacting adaptive functioning.

Area of Science:

  • Neurology
  • Developmental Psychology
  • Pediatrics

Background:

  • Epilepsy significantly impacts young people's independence compared to peers.
  • Intractable seizures in children pose risks to adaptive functioning.
  • Parental anxiety is a potential mediator in the epilepsy-adaptive functioning relationship.

Purpose of the Study:

  • Identify seizure-related risk factors for poor adaptive functioning in pediatric patients.
  • Examine direct and indirect effects of medical variables on adaptive functioning.
  • Investigate the role of parental anxiety in mediating these effects.

Main Methods:

  • Analyzed data from 97 pediatric patients with intractable seizures.
  • Evaluated seizure-related variables (e.g., anticonvulsants, seizure generalization, duration, age at onset).
  • Assessed parental anxiety levels and parental education.

Main Results:

  • Higher anticonvulsant numbers, generalized seizures, longer epilepsy duration, and younger age at onset were risk factors for poor adaptive functioning.
  • Effects were sometimes direct, sometimes indirect via parental anxiety.
  • Lower parental education and family history of seizures correlated with higher parental anxiety.

Conclusions:

  • Specific seizure characteristics and early onset negatively affect adaptive functioning in pediatric epilepsy.
  • Parental anxiety plays a significant role, influenced by parental education and family history.
  • Interventions targeting parental anxiety may improve social development outcomes for children with epilepsy.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
371
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
1